Clinical Scorecard: Achieving Patient Adherence to IOP-Lowering Drugs

At a Glance

Key Highlights

• Patient education on glaucoma seriousness and direct link between nonadherence and vision loss improves adherence.
• Demonstrating proper eye drop instillation and discussing side effects preemptively addresses common barriers.
• Integrating medication use into patients' daily routines and using visual aids and technology enhances habitual adherence.

Guideline-Based Recommendations

Diagnosis

• Explain glaucoma nature and progression clearly to patients before discussing treatment adherence.

Management

• Provide verbal and visual education linking nonadherence to risk of blindness and need for aggressive interventions.
• Demonstrate proper drop instillation technique: pull lower lid down to create a pocket, instill drop without touching eye or lid.
• Discuss potential side effects such as headaches to preempt nonadherence.
• Simplify medication regimens and consider adherence-aiding technology.
• Consider switching to preservative-free drops for patients with ocular dryness.
• Offer financial assistance resources and consider generic alternatives cautiously due to variability.

Monitoring & Follow-up

• Regularly inquire about patients' daily routines to integrate medication use and identify adherence barriers.

Risks

• Nonadherence can cause fluctuating IOP, accelerating optic nerve damage and irreversible vision loss.
• Poor adherence may lead to need for surgeries, hospitalizations, and increased patient costs.

Patient & Prescribing Data

Glaucoma patients prescribed IOP-lowering eye drops

Education on eye drop administration is significantly linked to improved adherence; visual aids and routine integration support sustained use.

Clinical Best Practices

• Always remind patients to wash hands and avoid touching eyes directly during drop instillation.
• Use diagrams, eye models, and digital apps to visually demonstrate glaucoma progression and medication importance.
• Place medication near habitual morning activities (e.g., coffee maker) to serve as visual cues.
• Address financial barriers proactively by providing assistance resources.
• Evaluate the suitability of generic medications on a case-by-case basis due to variability in formulation and tolerability.

References

• Sleath B et al. Ophthalmologist-patient communication and glaucoma medication adherence. Ophthalmology. 2015
• Newman-Casey PA et al. Medication adherence and visual field progression. Ophthalmology. 2020
• Zaharia AC et al. Adherence to Therapy in Glaucoma Treatment - A Review. J Pers Med. 2022
• Gazzard G et al. LiGHT Trial: Laser vs Eye Drops for Glaucoma. Ophthalmology. 2023
• Wolfram C et al. Patient-Reported Nonadherence with Glaucoma Therapy. J Ocul Pharmacol Ther. 2019
• Tatham AJ. The Use of Generic Medications for Glaucoma. J Ophthalmol. 2020